Since the FDA resolved the shortages for both tirzepatide (December 2024) and semaglutide (early 2025), the window for legal compounding has narrowed significantly, and thousands of patients have found themselves needing to make this transition
1 But GLP-1 doesnt just impact appetiteit also supports metabolic health by improving insulin sensitivity and maintaining balanced blood sugar levels, both important for healthy weight management
For many, the advantages of improved glycemic control, significant weight loss, and reduced cardiovascular risk far outweigh the potential downsides, making Semaglutide a valuable therapeutic option in modern medicine.
Elegans and delays the progression of age-related diseases by activating AMPK, DAF-16, and HSF-1
We critically evaluate the emerging evidence demonstrating that MSC Exos are enriched with anti-ferroptotic miRNAs, antioxidant enzymes, and iron homeostasis regulators, which can mitigate cellular ferroptosis